LT2968221T - S-ketamino hidrochlorido farmacinė kompozicija - Google Patents

S-ketamino hidrochlorido farmacinė kompozicija

Info

Publication number: LT2968221T
Authority: LT; Lithuania
Prior art keywords: pharmaceutical composition; ketamine hydrochloride; ketamine; hydrochloride; pharmaceutical
Prior art date: 2013-03-15

Application number

LTEP14719471.6T

Other languages

English (en)

Inventor

Esther D. G. BASSTANIE

Johanna Bentz

Roger C.A. Embrechts

Nico Rudolph NIEMEIIJER

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-15

Filing date

2014-03-14

Publication date

2019-07-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50549465&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2968221(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-03-14 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2019-07-25 Publication of LT2968221T publication Critical patent/LT2968221T/lt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Otolaryngology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

LTEP14719471.6T 2013-03-15 2014-03-14 S-ketamino hidrochlorido farmacinė kompozicija LT2968221T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201361791505P	2013-03-15	2013-03-15
PCT/US2014/027074 WO2014143646A1 (en)	2013-03-15	2014-03-14	Pharmaceutical composition of s-ketamine hydrochloride

Publications (1)

Publication Number	Publication Date
LT2968221T true LT2968221T (lt)	2019-07-25

Family

ID=50549465

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEP14719471.6T LT2968221T (lt)	2013-03-15	2014-03-14	S-ketamino hidrochlorido farmacinė kompozicija

Country Status (26)

Country	Link
US (2)	US20140275277A1 (lt)
EP (3)	EP3498268A1 (lt)
KR (3)	KR20150129023A (lt)
CN (3)	CN116251084A (lt)
AU (6)	AU2014228324B2 (lt)
CL (1)	CL2015002733A1 (lt)
CR (1)	CR20150480A (lt)
CY (1)	CY1121928T1 (lt)
DK (1)	DK2968221T3 (lt)
ES (1)	ES2745024T3 (lt)
HR (1)	HRP20191477T1 (lt)
HU (1)	HUE045982T2 (lt)
LT (1)	LT2968221T (lt)
ME (1)	ME03465B (lt)
MX (2)	MX386479B (lt)
MY (2)	MY191332A (lt)
NZ (1)	NZ712270A (lt)
PE (2)	PE20191796A1 (lt)
PH (2)	PH12021552333A1 (lt)
PL (1)	PL2968221T3 (lt)
PT (1)	PT2968221T (lt)
RS (1)	RS59130B1 (lt)
SG (3)	SG10201912735TA (lt)
SI (1)	SI2968221T1 (lt)
SM (1)	SMT201900472T1 (lt)
WO (1)	WO2014143646A1 (lt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2897453T3 (es)	2013-09-13	2022-03-01	Univ Chiba Nat Univ Corp	Aplicación de R-ketamina y sal de la misma como productos farmacéuticos
EP3094312B1 (en)	2014-01-14	2019-03-13	Children's Hospital Medical Center	Compositions comprising ketamine for treating an autism spectrum disorder
US9844551B2 (en)	2015-01-14	2017-12-19	Children's Hospital Medical Center	Compositions and methods for treatment of fragile X syndrome
US20160332962A1 (en)	2015-05-13	2016-11-17	Janssen Pharmaceutica Nv	(s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
CN106562952B (zh) *	2015-10-09	2020-06-09	江阴安博生物医药有限公司	氯胺酮在治疗重性抑郁障碍中的应用
EP3609481A4 (en) *	2017-04-13	2021-05-26	Ovid Therapeutics Inc.	DEVELOPMENTAL ENCEPHALOPATHY TREATMENT METHODS
EP3641742A2 (en) *	2017-06-23	2020-04-29	Develco Pharma Schweiz AG	Hydroxynorketamine for the use in the treatment of depression
PT3505157T (pt)	2017-12-29	2022-02-18	Celon Pharma Sa	Composição de cetamina em pó seco para administração pulmonar em depressão resistente ao tratamento
WO2019160057A1 (ja)	2018-02-15	2019-08-22	国立大学法人千葉大学	炎症性疾患若しくは骨疾患の予防又は治療剤及び医薬組成物
EP3813808A4 (en)	2018-05-04	2022-01-26	Perception Neuroscience, Inc.	Methods of treating substance abuse
EP3628313B1 (en)	2018-09-28	2025-02-12	Novohale Therapeutics, LLC	Ketamine composition for use in a method of treatment of depression by pulmonary administration
US20220062200A1 (en) *	2019-05-07	2022-03-03	Clexio Biosciences Ltd.	Abuse-deterrent dosage forms containing esketamine
WO2020239243A1 (en)	2019-05-31	2020-12-03	Celon Pharma S.A.	Electronically supervised administration of a pharmaceutical composition
BR112021024141A2 (pt)	2019-05-31	2022-01-11	Celon Pharma Sa	Inalador para administração parenteral supervisionada eletronicamente de uma composição farmacêutica
US20220339123A1 (en) *	2019-09-13	2022-10-27	Janssen Pharmaceuticals, Inc.	Intranasal administration of esketamine
US11160799B2 (en) *	2019-10-22	2021-11-02	Cessatech A/S	Pediatric combination
TW202135787A (zh) *	2019-12-12	2021-10-01	比利時商健生藥品公司	艾氯胺酮調配物及製備與儲存的方法
CA3152593A1 (en) *	2019-12-20	2021-06-24	Tong-Ho Lin	Long-acting injectable formulations of ketamine pamoate salts
CN114903840A (zh) *	2021-02-08	2022-08-16	四川普锐特药业有限公司	一种治疗抑郁症的低剂量r-氯胺酮经鼻药物
CN113813250B (zh) *	2021-07-21	2023-05-05	广州新济药业科技有限公司	含氯胺酮的药物组合物及其制备方法和应用
CN116942648A (zh)	2022-04-26	2023-10-27	宜昌人福药业有限责任公司	艾司氯胺酮液体制剂及其用途
WO2023207728A1 (zh)	2022-04-26	2023-11-02	宜昌人福药业有限责任公司	艾司氯胺酮液体制剂及其用途
AU2023390101A1 (en) *	2022-12-07	2025-06-19	Freedom Biosciences, Inc.	Treatment or prevention of depressive disorders through combination therapy
WO2025037252A1 (en) *	2023-08-14	2025-02-20	Javitt Daniel C	Compositions and methods for treatment of chronic pain and depression
US12005035B1 (en) *	2023-08-14	2024-06-11	Daniel C. Javitt	Compositions and methods for treatment of chronic pain and depression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4312016A1 (de)	1993-04-13	1994-10-20	Goedecke Ag	Stabile Ketamin-Lösungen
WO2002024116A1 (en) *	2000-09-20	2002-03-28	Shahinian, Lee, Jr.	Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications
US6881731B1 (en)	2000-10-23	2005-04-19	Shanbrom Technologies, Llc	Enhancers for microbiological disinfection
CN101466364A (zh) *	2006-03-22	2009-06-24	纽约大学西奈山医学院	鼻内施用氯胺酮治疗抑郁症
DE102007009888A1 (de) *	2007-02-28	2008-09-04	Hermann, Holger Lars, Dr.	Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen
MX2015002378A (es) *	2012-08-23	2015-09-25	Stuart L Weg	Composicion ansiolitica, formulacion y metodo de uso.

2014
- 2014-03-14 EP EP19151099.9A patent/EP3498268A1/en not_active Withdrawn
- 2014-03-14 ME MEP-2019-229A patent/ME03465B/me unknown
- 2014-03-14 EP EP23194654.2A patent/EP4309735A3/en active Pending
- 2014-03-14 PT PT14719471T patent/PT2968221T/pt unknown
- 2014-03-14 ES ES14719471T patent/ES2745024T3/es active Active
- 2014-03-14 MX MX2019000742A patent/MX386479B/es unknown
- 2014-03-14 MY MYPI2015703106A patent/MY191332A/en unknown
- 2014-03-14 SI SI201431255T patent/SI2968221T1/sl unknown
- 2014-03-14 CN CN202310142376.5A patent/CN116251084A/zh active Pending
- 2014-03-14 PH PH1/2021/552333A patent/PH12021552333A1/en unknown
- 2014-03-14 SG SG10201912735TA patent/SG10201912735TA/en unknown
- 2014-03-14 SG SG10201802106TA patent/SG10201802106TA/en unknown
- 2014-03-14 PL PL14719471T patent/PL2968221T3/pl unknown
- 2014-03-14 LT LTEP14719471.6T patent/LT2968221T/lt unknown
- 2014-03-14 DK DK14719471.6T patent/DK2968221T3/da active
- 2014-03-14 PE PE2019002294A patent/PE20191796A1/es unknown
- 2014-03-14 NZ NZ712270A patent/NZ712270A/en unknown
- 2014-03-14 PE PE2015001997A patent/PE20160052A1/es active IP Right Grant
- 2014-03-14 WO PCT/US2014/027074 patent/WO2014143646A1/en not_active Ceased
- 2014-03-14 EP EP14719471.6A patent/EP2968221B1/en not_active Revoked
- 2014-03-14 US US14/212,988 patent/US20140275277A1/en not_active Abandoned
- 2014-03-14 KR KR1020157029474A patent/KR20150129023A/ko not_active Ceased
- 2014-03-14 KR KR1020217006306A patent/KR20210028278A/ko not_active Ceased
- 2014-03-14 HR HRP20191477 patent/HRP20191477T1/hr unknown
- 2014-03-14 SM SM20190472T patent/SMT201900472T1/it unknown
- 2014-03-14 AU AU2014228324A patent/AU2014228324B2/en active Active
- 2014-03-14 CN CN201911264371.XA patent/CN111297803A/zh active Pending
- 2014-03-14 CN CN201480015763.1A patent/CN105073103A/zh active Pending
- 2014-03-14 MX MX2015012342A patent/MX373678B/es active IP Right Grant
- 2014-03-14 KR KR1020237037938A patent/KR20230156807A/ko not_active Ceased
- 2014-03-14 US US14/212,565 patent/US20140275276A1/en not_active Abandoned
- 2014-03-14 HU HUE14719471A patent/HUE045982T2/hu unknown
- 2014-03-14 RS RS20191043A patent/RS59130B1/sr unknown
- 2014-03-14 SG SG11201507358VA patent/SG11201507358VA/en unknown
- 2014-03-14 MY MYPI2019005662A patent/MY203693A/en unknown
2015
- 2015-09-04 PH PH12015501957A patent/PH12015501957A1/en unknown
- 2015-09-11 CR CR20150480A patent/CR20150480A/es unknown
- 2015-09-15 CL CL2015002733A patent/CL2015002733A1/es unknown
2019
- 2019-02-01 AU AU2019200705A patent/AU2019200705B2/en active Active
- 2019-02-01 AU AU2019200696A patent/AU2019200696B2/en active Active
- 2019-02-01 AU AU2019200702A patent/AU2019200702B2/en active Active
- 2019-08-23 CY CY20191100904T patent/CY1121928T1/el unknown
2021
- 2021-01-07 AU AU2021200072A patent/AU2021200072A1/en not_active Abandoned
2023
- 2023-02-20 AU AU2023200976A patent/AU2023200976B2/en active Active

Also Published As

Publication number	Publication date
AU2019200702B2 (en)	2020-10-08
EP4309735A2 (en)	2024-01-24
KR20230156807A (ko)	2023-11-14
CR20150480A (es)	2015-10-26
SG10201912735TA (en)	2020-02-27
RS59130B1 (sr)	2019-09-30
NZ712270A (en)	2020-02-28
AU2023200976B2 (en)	2025-03-27
MX2015012342A (es)	2016-06-06
AU2023200976A1 (en)	2023-03-23
KR20150129023A (ko)	2015-11-18
PH12021552333A1 (en)	2022-08-01
HRP20191477T1 (hr)	2019-12-13
PH12015501957A1 (en)	2016-01-11
EP2968221B1 (en)	2019-06-19
BR112015022970A2 (pt)	2017-07-18
HUE045982T2 (hu)	2020-01-28
AU2019200696B2 (en)	2020-10-08
AU2019200696A1 (en)	2019-02-21
US20140275277A1 (en)	2014-09-18
SG10201802106TA (en)	2018-04-27
AU2014228324A1 (en)	2015-09-17
MY191332A (en)	2022-06-16
AU2014228324B2 (en)	2019-01-31
AU2019200705B2 (en)	2020-10-08
AU2021200072A1 (en)	2021-03-18
BR112015022970A8 (pt)	2019-11-26
PL2968221T3 (pl)	2020-01-31
ES2745024T3 (es)	2020-02-27
PT2968221T (pt)	2019-09-13
AU2019200702A1 (en)	2019-02-21
KR20210028278A (ko)	2021-03-11
CL2015002733A1 (es)	2016-03-04
SG11201507358VA (en)	2015-10-29
ME03465B (me)	2020-01-20
PE20160052A1 (es)	2016-01-28
AU2019200705A1 (en)	2019-02-21
CN105073103A (zh)	2015-11-18
WO2014143646A1 (en)	2014-09-18
CN111297803A (zh)	2020-06-19
SMT201900472T1 (it)	2019-09-09
CY1121928T1 (el)	2020-10-14
US20140275276A1 (en)	2014-09-18
EP2968221A1 (en)	2016-01-20
MY203693A (en)	2024-07-14
PE20191796A1 (es)	2019-12-24
SI2968221T1 (sl)	2019-08-30
DK2968221T3 (da)	2019-08-05
EP4309735A3 (en)	2024-04-17
EP3498268A1 (en)	2019-06-19
MX373678B (es)	2020-06-26
CN116251084A (zh)	2023-06-13
MX386479B (es)	2025-03-18

Publication	Publication Date	Title
FR21C1059I2 (fr)	2022-12-02	Compositions pharmaceutiques
LT2968221T (lt)	2019-07-25	S-ketamino hidrochlorido farmacinė kompozicija
PT3030262T (pt)	2019-12-11	Composição farmacêutica de associação
SG11201507347QA (en)	2015-10-29	Pharmaceutical composition of s-ketamine hydrochloride
DK3256138T3 (da)	2022-05-16	Farmaceutiske sammensætninger omfattende meloxicam
HRP20180684T1 (hr)	2018-06-01	Kombinacija lijekova
LT3080100T (lt)	2023-02-27	Lizinui specifinės demetilazės-1 inhibitoriai
LT2981255T (lt)	2022-11-25	Empagliflozino terapiniai panaudojimo būdai
HRP20190101T1 (hr)	2019-03-08	Terapeutske uporabe empagliflozina
EP2889350A4 (en)	2016-05-18	ADHESIVE COMPOSITION
DK2968214T3 (da)	2021-06-07	Hidtil ukendte analgetiske sammensætninger
EP2958994A4 (en)	2016-11-23	Vaccine composition
DK3027750T3 (da)	2019-07-15	Biokatalytisk sammensætning
DK2897594T3 (da)	2020-06-29	Farmaceutisk sammensætning
DK2988733T3 (da)	2019-07-01	Farmaceutisk sammensætning indeholdende krystallin macitentan
IL242220A0 (en)	2015-11-30	Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
DK3079667T3 (da)	2019-09-09	Farmaceutiske doseringsformer
DK3003401T3 (da)	2020-04-06	Farmaceutisk præparat
EP2988734C0 (en)	2024-12-25	FORMULATION OF A HARD CAPSULE
BR112015002646A2 (pt)	2018-02-06	composto e composição farmacêutica
EP3043648C0 (en)	2023-09-20	PHARMACEUTICAL COMPOSITIONS OF BENDAMUSTINE
HRP20182110T1 (hr)	2019-02-22	Sastav spojeva tiakumicina
DK3060213T3 (da)	2022-01-03	Farmaceutiske sammensætninger omfattende antibakterielle midler
PL2956129T3 (pl)	2018-09-28	Kompozycje farmaceutyczne zawierające deksketoprofen i tramadol
TH1501001236A (th)	2016-08-03	องค์ประกอบทางเภสัชกรรมซึ่งประกอบด้วย รีโกราเฟนิบ ที่ถูกเคลือบ